{"database": "lobbying", "table": "lobbying_activities", "rows": [[3054126, "107c6ded-81e3-4036-8f1d-41324c7c0144", "Q3", "BROWNSTEIN HYATT FARBER SCHRECK, LLP", 7257, "ROMARK GLOBAL PHARMA, LLC", 2023, "third_quarter", "PHA", "Issues regarding Biomedical Advanced Research and Development Authority Covid-19 Therapeutics' Pandemic All Hazards Preparedness Act", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2023-10-17T17:00:59-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3054126"], "units": {}, "query_ms": 146.05616801418364, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}